Sofinnova Investments, Inc. Applied Therapeutics Inc. Transaction History

Sofinnova Investments, Inc.

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2020 May 13, 2020	SELL	$19.54 - $55.47 $2.63 Million - $7.48 Million	-134,825 Closed	0 $0
Q4 2019 Feb 14, 2020	SELL	$10.16 - $28.14 $72,938 - $202,017	-7,179 Reduced 5.06%	134,825 $3.68 Million
Q2 2019 Aug 13, 2019	BUY	$8.1 - $10.05 $1.15 Million - $1.43 Million	142,004 New	142,004 $1.17 Million

143

111M

1.68M

1.91M

Ticker APLT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 48,020,700
Market Cap $29.3M
Description
Applied Therapeutics, Inc., a clinical-stage biopharmaceutical company, develops novel products to target cardiovascular disease, galactosemia, and diabetic complications. Its lead product candidate is AT-007 that has completed phase 1/2 for the treatment of galactosemia in healthy volunteers and adults, as well as is in pediatric clinical study...

Get notified when there are updates to the investment portfolio of Sofinnova Investments, Inc., based on Form 13F filings with the SEC.

Stay updated on Sofinnova Investments, Inc. with notifications on news.